These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10530805)

  • 21. Functional coupling between adenosine A
    Odagaki Y; Kinoshita M; Ota T; Meana JJ; Callado LF; Matsuoka I; García-Sevilla JA
    Purinergic Signal; 2018 Jun; 14(2):177-190. PubMed ID: 29492786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gamma-hydroxybutyric acid, unlike gamma-aminobutyric acid, does not stimulate Gi/Go proteins in rat brain membranes.
    Odagaki Y; Yamauchi T
    Basic Clin Pharmacol Toxicol; 2004 Feb; 94(2):89-98. PubMed ID: 14748852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies of micro-, kappa-, and delta-opioid receptor density and G protein activation in the cortex and thalamus of monkeys.
    Ko MC; Lee H; Harrison C; Clark MJ; Song HF; Naughton NN; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2003 Jul; 306(1):179-86. PubMed ID: 12676881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro autoradiographic visualization of guanosine-5'-O-(3-[35S]thio)triphosphate binding stimulated by sphingosine 1-phosphate and lysophosphatidic acid.
    Waeber C; Chiu ML
    J Neurochem; 1999 Sep; 73(3):1212-21. PubMed ID: 10461914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The putative <> 5-HT(1A) receptor antagonist, WAY 100635, has inverse agonist properties at cloned human 5-HT(1A) receptors.
    Cosi C; Koek W
    Eur J Pharmacol; 2000 Jul; 401(1):9-15. PubMed ID: 10915831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nucleoside diphosphate kinase associated with membranes modulates mu-opioid receptor-mediated [35S]GTPgammaS binding and agonist binding to mu-opioid receptor.
    Zhang D; Li JG; Chen C; Liu-Chen LY
    Eur J Pharmacol; 1999 Jul; 377(2-3):223-31. PubMed ID: 10456435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. P2 purinergic receptors for diadenosine polyphosphates in the nervous system.
    Pintor J; Miras-Portugal MT
    Gen Pharmacol; 1995 Mar; 26(2):229-35. PubMed ID: 7590071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selectivity of diadenosine polyphosphates for rat P2X receptor subunits.
    Wildman SS; Brown SG; King BF; Burnstock G
    Eur J Pharmacol; 1999 Feb; 367(1):119-23. PubMed ID: 10082274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-HT1A receptor-mediated G protein activation assessed by [35S]GTPgammaS binding in rat cerebral cortex.
    Odagaki Y; Toyoshima R
    Eur J Pharmacol; 2005 Oct; 521(1-3):49-58. PubMed ID: 16182280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain.
    Sóvágó J; Makkai B; Gulyás B; Hall H
    Eur J Neurosci; 2005 Jul; 22(1):65-71. PubMed ID: 16029196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ap4A and ADP-beta-S binding to P2 purinoceptors present on rat brain synaptic terminals.
    Pintor J; Díaz-Rey MA; Miras-Portugal MT
    Br J Pharmacol; 1993 Apr; 108(4):1094-9. PubMed ID: 8485620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assay of G protein-coupled receptor activation of G proteins in native cell membranes using [35S]GTP gamma S binding.
    Bidlack JM; Parkhill AL
    Methods Mol Biol; 2004; 237():135-43. PubMed ID: 14501046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
    Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ
    J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of ATP and P2 agonists binding to the cardiac plasma membrane P1,P4-diadenosine 5'-tetraphosphate receptor.
    Blouse GE; Liu G; Hilderman RH
    Biochim Biophys Acta; 1998 Oct; 1375(1-2):61-72. PubMed ID: 9767112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of ryanodine receptor calcium release channels by diadenosine polyphosphates.
    Holden CP; Padua RA; Geiger JD
    J Neurochem; 1996 Aug; 67(2):574-80. PubMed ID: 8764582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High affinity P2x-purinoceptor binding sites for [35S]-adenosine 5'-O-[3-thiotriphosphate] in rat vas deferens membranes.
    Michel AD; Humphrey PP
    Br J Pharmacol; 1996 Jan; 117(1):63-70. PubMed ID: 8825344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotonin 5-HT(1B/1D) agonist-stimulated [(35)S]GTPgammaS binding in rat and guinea pig striatal membranes.
    Mize AL; Alper RH
    Brain Res; 1999 Jul; 836(1-2):229-36. PubMed ID: 10415426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-Hydroxytryptamine1A and 5-hydroxytryptamine1B receptors stimulate [35S]guanosine-5'-O-(3-thio)triphosphate binding to rodent brain sections as visualized by in vitro autoradiography.
    Waeber C; Moskowitz MA
    Mol Pharmacol; 1997 Oct; 52(4):623-31. PubMed ID: 9380025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The activation of P1- and P2-purinoceptors in the guinea-pig left atrium by diadenosine polyphosphates.
    Hoyle CH; Ziganshin AU; Pintor J; Burnstock G
    Br J Pharmacol; 1996 Jul; 118(5):1294-300. PubMed ID: 8818356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes.
    Odagaki Y; Toyoshima R
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1304-12. PubMed ID: 16824659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.